Zydus Lifesciences (ZYDUSLIFE) — Corporate Action

Zydus Lifesciences initiated the IEPFA-mandated 100-day 'Saksham Niveshak' campaign (July 28–November 6, 2025) targeting shareholders with unpaid or unclaimed dividends. Shareholders must update KYC and nomination details and claim dividends through the RTA (MUFG Intime India Private Limited) or the Nodal Officer to prevent share transfer to IEPFA. This is a regulatory compliance notice requiring shareholder action.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this corporate action affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 13 September 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 13 September 2025

COALINDIA Coal India Limited Insider Trading LT Larsen & Toubro Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.